Effective management of acute hemorrhage using an SL One® rapid infusion device in a pediatric patient undergoing nephrectomy for Wilms tumor with inferior vena cava extension: a case report

Abstract Background Wilms tumor is the most common pediatric renal tumor. Tumor extension into the inferior vena cava (IVC) can increase hemorrhage risk during surgical resection, necessitating rapid transfusion. Pediatric patients have lower circulating blood volume, heightening their susceptibilit...

Full description

Saved in:
Bibliographic Details
Main Authors: Shoko Fujioka, Yusuke Miyazaki, Hinako Furuya, Chika Miyazaki, Nobuyuki Katori, Yoshie Taniguchi
Format: Article
Language:English
Published: SpringerOpen 2025-05-01
Series:JA Clinical Reports
Subjects:
Online Access:https://doi.org/10.1186/s40981-025-00788-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850190825708847104
author Shoko Fujioka
Yusuke Miyazaki
Hinako Furuya
Chika Miyazaki
Nobuyuki Katori
Yoshie Taniguchi
author_facet Shoko Fujioka
Yusuke Miyazaki
Hinako Furuya
Chika Miyazaki
Nobuyuki Katori
Yoshie Taniguchi
author_sort Shoko Fujioka
collection DOAJ
description Abstract Background Wilms tumor is the most common pediatric renal tumor. Tumor extension into the inferior vena cava (IVC) can increase hemorrhage risk during surgical resection, necessitating rapid transfusion. Pediatric patients have lower circulating blood volume, heightening their susceptibility to hemodynamic instability. Case presentation A 2-year-old boy with an IVC-extending Wilms tumor underwent nephrectomy. Anticipating hemorrhage, we employed an SL One® rapid infusion device via a Broviac™ central venous catheter. During a sudden, high-volume bleeding, transfusion was initiated at 23 mL/min and intermittently increased to 150 mL/min while preload was evaluated using transesophageal echocardiography, rapidly stabilizing hemodynamics. No rapid-transfusion-related complications, such as hyperkalemia or hypothermia, were observed, and the postoperative course was uneventful. Conclusions In this pediatric case at high risk for acute blood loss, the SL One® provided effective circulatory stabilization without adverse events. Further studies are needed to validate the safety of the SL One® in pediatric patients.
format Article
id doaj-art-ba7605af8fd24430b09bd94a3fdaae54
institution OA Journals
issn 2363-9024
language English
publishDate 2025-05-01
publisher SpringerOpen
record_format Article
series JA Clinical Reports
spelling doaj-art-ba7605af8fd24430b09bd94a3fdaae542025-08-20T02:15:08ZengSpringerOpenJA Clinical Reports2363-90242025-05-011111510.1186/s40981-025-00788-7Effective management of acute hemorrhage using an SL One® rapid infusion device in a pediatric patient undergoing nephrectomy for Wilms tumor with inferior vena cava extension: a case reportShoko Fujioka0Yusuke Miyazaki1Hinako Furuya2Chika Miyazaki3Nobuyuki Katori4Yoshie Taniguchi5Department of Anesthesiology, The Jikei University School of MedicineDepartment of Anesthesiology, The Jikei University School of MedicineDepartment of Anesthesiology, The Jikei University School of MedicineDepartment of Anesthesiology, The Jikei University School of MedicineDepartment of Anesthesiology, The Jikei University School of MedicineDepartment of Anesthesiology, The Jikei University School of MedicineAbstract Background Wilms tumor is the most common pediatric renal tumor. Tumor extension into the inferior vena cava (IVC) can increase hemorrhage risk during surgical resection, necessitating rapid transfusion. Pediatric patients have lower circulating blood volume, heightening their susceptibility to hemodynamic instability. Case presentation A 2-year-old boy with an IVC-extending Wilms tumor underwent nephrectomy. Anticipating hemorrhage, we employed an SL One® rapid infusion device via a Broviac™ central venous catheter. During a sudden, high-volume bleeding, transfusion was initiated at 23 mL/min and intermittently increased to 150 mL/min while preload was evaluated using transesophageal echocardiography, rapidly stabilizing hemodynamics. No rapid-transfusion-related complications, such as hyperkalemia or hypothermia, were observed, and the postoperative course was uneventful. Conclusions In this pediatric case at high risk for acute blood loss, the SL One® provided effective circulatory stabilization without adverse events. Further studies are needed to validate the safety of the SL One® in pediatric patients.https://doi.org/10.1186/s40981-025-00788-7SL One®Rapid infusion deviceHemorrhageChildWilms tumor
spellingShingle Shoko Fujioka
Yusuke Miyazaki
Hinako Furuya
Chika Miyazaki
Nobuyuki Katori
Yoshie Taniguchi
Effective management of acute hemorrhage using an SL One® rapid infusion device in a pediatric patient undergoing nephrectomy for Wilms tumor with inferior vena cava extension: a case report
JA Clinical Reports
SL One®
Rapid infusion device
Hemorrhage
Child
Wilms tumor
title Effective management of acute hemorrhage using an SL One® rapid infusion device in a pediatric patient undergoing nephrectomy for Wilms tumor with inferior vena cava extension: a case report
title_full Effective management of acute hemorrhage using an SL One® rapid infusion device in a pediatric patient undergoing nephrectomy for Wilms tumor with inferior vena cava extension: a case report
title_fullStr Effective management of acute hemorrhage using an SL One® rapid infusion device in a pediatric patient undergoing nephrectomy for Wilms tumor with inferior vena cava extension: a case report
title_full_unstemmed Effective management of acute hemorrhage using an SL One® rapid infusion device in a pediatric patient undergoing nephrectomy for Wilms tumor with inferior vena cava extension: a case report
title_short Effective management of acute hemorrhage using an SL One® rapid infusion device in a pediatric patient undergoing nephrectomy for Wilms tumor with inferior vena cava extension: a case report
title_sort effective management of acute hemorrhage using an sl one r rapid infusion device in a pediatric patient undergoing nephrectomy for wilms tumor with inferior vena cava extension a case report
topic SL One®
Rapid infusion device
Hemorrhage
Child
Wilms tumor
url https://doi.org/10.1186/s40981-025-00788-7
work_keys_str_mv AT shokofujioka effectivemanagementofacutehemorrhageusinganslonerapidinfusiondeviceinapediatricpatientundergoingnephrectomyforwilmstumorwithinferiorvenacavaextensionacasereport
AT yusukemiyazaki effectivemanagementofacutehemorrhageusinganslonerapidinfusiondeviceinapediatricpatientundergoingnephrectomyforwilmstumorwithinferiorvenacavaextensionacasereport
AT hinakofuruya effectivemanagementofacutehemorrhageusinganslonerapidinfusiondeviceinapediatricpatientundergoingnephrectomyforwilmstumorwithinferiorvenacavaextensionacasereport
AT chikamiyazaki effectivemanagementofacutehemorrhageusinganslonerapidinfusiondeviceinapediatricpatientundergoingnephrectomyforwilmstumorwithinferiorvenacavaextensionacasereport
AT nobuyukikatori effectivemanagementofacutehemorrhageusinganslonerapidinfusiondeviceinapediatricpatientundergoingnephrectomyforwilmstumorwithinferiorvenacavaextensionacasereport
AT yoshietaniguchi effectivemanagementofacutehemorrhageusinganslonerapidinfusiondeviceinapediatricpatientundergoingnephrectomyforwilmstumorwithinferiorvenacavaextensionacasereport